Mattei Tobias A, Beer Jennifer, Teles Alisson R, Rehman Azeem A, Aldag Jean, Dinh Dzung
Neurosurgery & Spine Specialists - Eastern Maine Medical Center, Bangor, ME, USA.
University of Illinois College of Medicine at Peoria, IL, USA.
Global Spine J. 2017 Aug;7(5):452-459. doi: 10.1177/2192568217712714. Epub 2017 Jul 7.
The authors performed a retrospective controlled study of patients diagnosed with lumbar degenerative disc disease who received surgical intervention (either total disc replacement [TDR]/Activ-L or anterior lumbar interbody fusion [ALIF]) at a single tertiary-care hospital from 2007-2010.
To investigate the clinical outcomes after TDR in comparison with ALIF for surgical treatment of lumbar degenerative disc disease (DDD).
Analyzed data included intra-operative blood loss, time to return to work, and clinical outcomes as evaluated through the Oswestry Disability Index (ODI) and the Visual Analog Scale (VAS) pain questionnaires pre-operatively and at 6 weeks, 3 months, 6 months, and 1 year postoperative follow-up.
At the univariate analysis, patients submitted to TDR presented significantly lower VAS pain scores than patients who received ALIF starting at 6 weeks ( < .001) and continuing through one year postoperatively ( = .007). Patients submitted to TDR also presented significantly lower ODI disability scores at all time points. There was a significant difference in the number of days to return to work, with TDR patients returning to work on average 65 days sooner than ALIF patients ( = .011). There was no significant difference in the total blood loss between both groups.
The results of this retrospective controlled study suggest that, in comparison with patients submitted to ALIF, patients submitted to TDR present quicker return to work, less back pain, and lower disability scores at 1 year follow-up.
作者对2007年至2010年期间在一家三级医疗中心接受手术干预(全椎间盘置换术[TDR]/Activ-L或前路腰椎椎间融合术[ALIF])的腰椎退行性椎间盘疾病患者进行了一项回顾性对照研究。
比较TDR和ALIF治疗腰椎退行性椎间盘疾病(DDD)的临床疗效。
分析的数据包括术中失血量、恢复工作时间,以及通过Oswestry功能障碍指数(ODI)和视觉模拟量表(VAS)疼痛问卷在术前、术后6周、3个月、6个月和1年随访时评估的临床疗效。
在单因素分析中,接受TDR的患者从术后6周开始(P<0.001)至术后1年(P = 0.007),VAS疼痛评分显著低于接受ALIF的患者。接受TDR的患者在所有时间点的ODI功能障碍评分也显著更低。恢复工作的天数有显著差异,TDR患者平均比ALIF患者早65天恢复工作(P = 0.011)。两组之间的总失血量无显著差异。
这项回顾性对照研究的结果表明,与接受ALIF的患者相比,接受TDR的患者在1年随访时恢复工作更快、背痛更少且功能障碍评分更低。